PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WRK vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WRK and WST is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

WRK vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WestRock Company (WRK) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%JulyAugustSeptemberOctoberNovemberDecember
2.59%
1.98%
WRK
WST

Key characteristics

Fundamentals

Market Cap

WRK:

$13.30B

WST:

$24.21B

EPS

WRK:

$1.21

WST:

$6.75

PE Ratio

WRK:

42.57

WST:

49.52

PEG Ratio

WRK:

1.76

WST:

6.24

Total Revenue (TTM)

WRK:

$9.35B

WST:

$2.88B

Gross Profit (TTM)

WRK:

$1.47B

WST:

$1.00B

EBITDA (TTM)

WRK:

$1.17B

WST:

$743.90M

Returns By Period


WRK

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

WST

YTD

-6.18%

1M

4.10%

6M

-0.30%

1Y

-6.92%

5Y*

17.27%

10Y*

20.43%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WRK vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for WestRock Company (WRK) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WRK, currently valued at 1.29, compared to the broader market-4.00-2.000.002.001.29-0.17
The chart of Sortino ratio for WRK, currently valued at 2.39, compared to the broader market-4.00-2.000.002.004.002.390.03
The chart of Omega ratio for WRK, currently valued at 1.36, compared to the broader market0.501.001.502.001.361.00
The chart of Calmar ratio for WRK, currently valued at 0.72, compared to the broader market0.002.004.006.000.72-0.16
The chart of Martin ratio for WRK, currently valued at 4.87, compared to the broader market-5.000.005.0010.0015.0020.0025.004.87-0.34
WRK
WST


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
1.29
-0.17
WRK
WST

Dividends

WRK vs. WST - Dividend Comparison

WRK has not paid dividends to shareholders, while WST's dividend yield for the trailing twelve months is around 0.25%.


TTM20232022202120202019201820172016201520142013
WRK
WestRock Company
1.17%2.72%2.92%2.10%2.45%4.26%4.62%2.58%3.00%2.64%1.17%1.81%
WST
West Pharmaceutical Services, Inc.
0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%

Drawdowns

WRK vs. WST - Drawdown Comparison


-45.00%-40.00%-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%JulyAugustSeptemberOctoberNovemberDecember
-10.39%
-29.58%
WRK
WST

Volatility

WRK vs. WST - Volatility Comparison

The current volatility for WestRock Company (WRK) is 0.00%, while West Pharmaceutical Services, Inc. (WST) has a volatility of 6.26%. This indicates that WRK experiences smaller price fluctuations and is considered to be less risky than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember0
6.26%
WRK
WST

Financials

WRK vs. WST - Financials Comparison

This section allows you to compare key financial metrics between WestRock Company and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab